British Journal of Oral and Maxillofacial Surgery
Volume 46, Issue 2 , Pages 90-95 , March 2008

Oral mucosal diseases: Erythema multiforme

  • Crispian Scully

      Affiliations

    • University College London, Eastman Dental Institute, UK
    • Corresponding Author InformationCorresponding author at: Eastman Dental Institute, University College London, 256 Gray's Inn Road, London WC1X 8LD, UK. Tel.: +44 20 7915 1038; fax: +44 20 7915 1039.
    • ,
  • Jose Bagan

      Affiliations

    • Service of Stomatology, University General Hospital, Valencia, Spain

,Accepted 19 July 2007.

References 

  1. Williams PM, Conklin RJ. Erythema multiforme: a review and contrast from Stevens–Johnson syndrome/toxic epidermal necrolysis. Dent Clin North Am. 2005;49:67–76
  2. Farthing P, Bagan JV, Scully C. Mucosal disease series. Number IV. Erythema multiforme. Oral Dis. 2005;11:261–267
  3. Letko E, Papaliodis DN, Papaliodis GN, Daoud YJ, Ahmed AR, Foster CS. Stevens–Johnson syndrome and toxic epidermal necrolysis: a review of the literature. Ann Allergy Asthma Immunol. 2005;94:419–436
  4. Hussain W, Craven NM. Toxic epidermal necrolysis and Stevens–Johnson syndrome. Clin Med. 2005;5:555–558
  5. Ayangco L, Rogers RS. Oral manifestations of erythema multiforme. Dermatol Clin. 2003;21:195–205
  6. Carrozzo M, Togliatto M, Gandolfo S. Eritema multiforme. Un fenotipo patologico eterogeneo. [Erythema multiforme. A heterogeneous pathologic phenotype]. Minerva Stomatol. 1999;48:217–226
  7. Farthing PM, Maragou P, Coates M, Tatnall F, Leigh IM, Williams DM. Characteristics of the oral lesions in patients with cutaneous recurrent erythema multiforme. J Oral Pathol Med. 1995;24:9–13
  8. Leigh IM, Mowbray JF, Levene GM, Sutherland S. Recurrent and continuous erythema multiforme—a clinical and immunological study. Clin Exp Dermatol. 1985;10:58–67
  9. Nesbit SP, Gobetti JP. Multiple recurrence of oral erythema multiforme after secondary herpes simplex: report of case and review of literature. J Am Dent Assoc. 1986;112:348–352
  10. Huff JC, Weston WL. Recurrent erythema multiforme. Medicine (Baltimore). 1989;68:133–140
  11. Brice SL, Krzemien D, Weston WL, Huff JC. Detection of herpes simplex virus DNA in cutaneous lesions of erythema multiforme. J Invest Dermatol. 1989;93:183–187
  12. Darragh TM, Egbert BM, Berger TG, Yen TS. Identification of herpes simplex virus DNA in lesions of erythema multiforme by the polymerase chain reaction. J Am Acad Dermatol. 1991;24:23–26
  13. Aslanzadeh J, Helm KF, Espy MJ, Muller SA, Smith TF. Detection of HSV-specific DNA in biopsy tissue of patients with erythema multiforme by polymerase chain reaction. Br J Dermatol. 1992;126:19–23
  14. Miura S, Smith CC, Burnett JW, Aurelian L. Detection of viral DNA within skin of healed recurrent herpes simplex infection and erythema multiforme lesions. J Invest Dermatol. 1992;98:68–72
  15. Imafuku S, Kokuba H, Aurelian L, Burnett J. Expression of herpes simplex virus DNA fragments located in epidermal keratinocytes and germinative cells is associated with the development of erythema multiforme lesions. J Invest Dermatol. 1997;109:550–556
  16. Kokuba H, Imafuku S, Burnett JW, Aurelian L. Longitudinal study of a patient with herpes-simplex-virus-associated erythema multiforme: viral gene expression and T cell repertoire usage. Dermatology. 1999;198:233–242
  17. Sun Y, Chan RK, Tan SH, Ng PP. Detection and genotyping of human herpes simplex viruses in cutaneous lesions of erythema multiform by nested PCR. J Med Virol. 2003;71:423–428
  18. Abdollahi M, Radfar M. A review of drug-induced oral reactions. J Contemp Dent Pract. 2003;4:10–31
  19. Scully C, Bagan JV. Adverse drug reactions in the orofacial region. Crit Rev Oral Biol Med. 2004;15:221–239
  20. Diz Dios P, Scully C. Adverse effects of antiretroviral therapy: focus on orofacial effects. Expert Opin Drug Saf. 2002;1:307–317
  21. Lin MS, Dai YS, Pwu RF, Chen YH, Chang NC. Risk estimates for drugs suspected of being associated with Stevens–Johnson syndrome and toxic epidermal necrolysis: a case-control study. Intern Med J. 2005;35:188–190
  22. Stewart MG, Duncan NO, Franklin DJ, Friedman EM, Sulek M. Head and neck manifestations of erythema multiforme in children. Otolaryngol Head Neck Surg. 1994;111:236–242
  23. Wohrl S, Loewe R, Pickl WF, Stingl G, Wagner SN. EMPACT syndrome. J Dtsch Dermatol Ges. 2005;3:39–43
  24. Ono F, Sharma BK, Smith CC, Burnett JW, Aurelian L. CD34+ cells in the peripheral blood transport herpes simplex virus DNA fragments to the skin of patients with erythema multiforme (HAEM). J Invest Dermatol. 2005;124:1215–1224
  25. Malmstrom M, Ruokonen H, Konttinen YT, Bergroth V, Segerberg-Konttinen M, Hietanen J, et al. Herpes simplex virus antigens and inflammatory cells in oral lesions in recurrent erythema multiforme. Immunoperoxidase and autoradiographic studies. Acta Derm Venereol. 1990;70:405–410
  26. Kokuba H, Imafuku S, Huang S, Aurelian L, Burnett JW. Erythema multiforme lesions are associated with expression of a herpes simplex virus (HSV) gene and qualitative alterations in the HSV-specific T-cell response. Br J Dermatol. 1998;138:952–964
  27. Knowles SR, Uetrecht J, Shear NH. Idiosyncratic drug reactions: the reactive metabolite syndromes. Lancet. 2000;356:1587–1591
  28. Paul C, Wolkenstein P, Adle H, et al. Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis. Br J Dermatol. 1996;134:710–714
  29. Caproni M, Torchia D, Schincaglia E, et al. The CD40/CD40 ligand system is expressed in the cutaneous lesions of erythema multiforme and Stevens–Johnson syndrome/toxic epidermal necrolysis spectrum. Br J Dermatol. 2006;154:319–324
  30. Auquier-Dunant A, Mockenhaupt M, Naldi L, Correia O, Schroder W, Roujeau JC. Correlations between clinical patterns and causes of erythema multiforme majus. Stevens–Johnson syndrome and toxic epidermal necrolysis: results of an international prospective study. Arch Dermatol. 2002;138:1019–1024
  31. Huff JC, Weston WL, Tonnesen MG. Erythema multiforme: a critical review of characteristics, diagnostic criteria, and causes. J Am Acad Dermatol. 1983;8:763–775
  32. de Roux Serratrice C, Serratrice J, Granel B, et al. Syndrome de Stevens–Johnson suivi d’un syndrome de Gougerot-Sjogren. [Stevens–Johnson syndrome followed by Gougerot-Sjogren syndrome]. Presse Med. 2001;30:531–532
  33. Schofield JK, Tatnall FM, Leigh IM. Recurrent erythema multiforme: clinical features and treatment in a large series of patients. Br J Dermatol. 1993;128:542–545
  34. Conejo-Mir JS, del Canto S, Munoz MA, et al. Thalidomide as elective treatment in persistent erythema multiforme; report of two cases. J Drugs Dermatol. 2003;2:40–44
  35. Geraminejad P, Walling HW, Voigt MD, Stone MS. Severe erythema multiforme responding to interferon alfa. J Am Acad Dermatol. 2006;54(Suppl):S18–S21
  36. Bakis S, Zagarella S. Intermittent oral cyclosporin for recurrent herpes simplex-associated erythema multiforme. Australas J Dermatol. 2005;46:18–20

PII: S0266-4356(07)00376-2

doi: 10.1016/j.bjoms.2007.07.202

British Journal of Oral and Maxillofacial Surgery
Volume 46, Issue 2 , Pages 90-95 , March 2008

Article Tools

* Image Usage & Resolution